ES529007A0 - Procedimiento para la fabricacion de derivados aminados de la piridazina substituidos en posicion 6 por un heterociclo o un aliciclo, activos sobre el sistema nervioso central. - Google Patents

Procedimiento para la fabricacion de derivados aminados de la piridazina substituidos en posicion 6 por un heterociclo o un aliciclo, activos sobre el sistema nervioso central.

Info

Publication number
ES529007A0
ES529007A0 ES529007A ES529007A ES529007A0 ES 529007 A0 ES529007 A0 ES 529007A0 ES 529007 A ES529007 A ES 529007A ES 529007 A ES529007 A ES 529007A ES 529007 A0 ES529007 A0 ES 529007A0
Authority
ES
Spain
Prior art keywords
nervous system
central nervous
piridazine
alicycle
hetero
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES529007A
Other languages
English (en)
Other versions
ES8407043A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES8407043A1 publication Critical patent/ES8407043A1/es
Publication of ES529007A0 publication Critical patent/ES529007A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES529007A 1983-01-24 1984-01-19 Procedimiento para la fabricacion de derivados aminados de la piridazina substituidos en posicion 6 por un heterociclo o un aliciclo, activos sobre el sistema nervioso central. Granted ES529007A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8301029A FR2539742B1 (fr) 1983-01-24 1983-01-24 Derives amines de la pyridazine substitues en position 6 par un heterocycle ou un alicycle, lesdits derives etant actifs sur le systeme nerveux central

Publications (2)

Publication Number Publication Date
ES8407043A1 ES8407043A1 (es) 1984-09-01
ES529007A0 true ES529007A0 (es) 1984-09-01

Family

ID=9285222

Family Applications (1)

Application Number Title Priority Date Filing Date
ES529007A Granted ES529007A0 (es) 1983-01-24 1984-01-19 Procedimiento para la fabricacion de derivados aminados de la piridazina substituidos en posicion 6 por un heterociclo o un aliciclo, activos sobre el sistema nervioso central.

Country Status (24)

Country Link
US (1) US4524070A (es)
EP (1) EP0117171B1 (es)
JP (1) JPS59139367A (es)
KR (1) KR910000641B1 (es)
AT (1) ATE28077T1 (es)
AU (1) AU560542B2 (es)
CA (1) CA1218063A (es)
CS (1) CS241539B2 (es)
DD (1) DD238793A5 (es)
DE (1) DE3464491D1 (es)
DK (1) DK31584A (es)
ES (1) ES529007A0 (es)
FI (1) FI840268A (es)
FR (1) FR2539742B1 (es)
GR (1) GR81717B (es)
HU (1) HU192390B (es)
IE (1) IE840150L (es)
IL (1) IL70757A (es)
NO (1) NO840244L (es)
NZ (1) NZ206907A (es)
PT (1) PT77982B (es)
SU (1) SU1189345A3 (es)
YU (1) YU12384A (es)
ZA (1) ZA84501B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141628A (en) * 1987-08-19 1992-08-25 Rwe-Entsorgung Aktiengesellschaft Method of cleaning and regenerating used oils
FR2665442B1 (fr) * 1990-07-31 1992-12-04 Sanofi Sa Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
US5461053A (en) * 1989-02-07 1995-10-24 Sanofi Pyridazine derivatives
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
PT93060B (pt) 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
AU2005260102A1 (en) * 2004-05-08 2006-01-12 Novartis International Pharmaceutical Ltd. 3-aryl-5,6-disubstituted pyridazines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292443A (en) * 1968-11-01 1972-10-11 Ct D Etudes Experimentales Et New pyridazine derivatives and process for their preparation
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives

Also Published As

Publication number Publication date
DD238793A5 (de) 1986-09-03
JPS59139367A (ja) 1984-08-10
GR81717B (es) 1984-12-12
YU12384A (en) 1986-10-31
AU2372784A (en) 1984-07-26
PT77982B (fr) 1986-04-10
CA1218063A (en) 1987-02-17
KR910000641B1 (ko) 1991-01-31
IL70757A (en) 1986-12-31
ES8407043A1 (es) 1984-09-01
PT77982A (fr) 1984-02-01
SU1189345A3 (ru) 1985-10-30
KR840007409A (ko) 1984-12-07
AU560542B2 (en) 1987-04-09
ATE28077T1 (de) 1987-07-15
US4524070A (en) 1985-06-18
DK31584D0 (da) 1984-01-24
IE840150L (en) 1984-07-24
IL70757A0 (en) 1984-04-30
NZ206907A (en) 1987-03-31
EP0117171B1 (fr) 1987-07-01
FI840268A0 (fi) 1984-01-23
FR2539742B1 (fr) 1986-09-05
NO840244L (no) 1984-07-25
EP0117171A1 (fr) 1984-08-29
CS53084A2 (en) 1985-07-16
FR2539742A1 (fr) 1984-07-27
ZA84501B (en) 1984-09-26
DK31584A (da) 1984-07-25
FI840268A (fi) 1984-07-25
DE3464491D1 (en) 1987-08-06
HU192390B (en) 1987-06-29
CS241539B2 (en) 1986-03-13

Similar Documents

Publication Publication Date Title
ES2139638T3 (es) 1,4-piperazinas disustituidas para el tratamiento de las enfermedades del sistema nervioso central y de las enfermedades neuroendocrinas.
DK139287A (da) Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler
DK164937C (da) Analogifremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater eller farmaceutisk acceptable syreadditionssalte deraf samt 1-alkyl-2-aminotetralinderivater til anvendelse som udgangsmateriale i fremgangsmaaden
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
ATE181329T1 (de) Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung
KR940005274A (ko) 쇼그렌(Sjoegren)증후군 치료제
ES529007A0 (es) Procedimiento para la fabricacion de derivados aminados de la piridazina substituidos en posicion 6 por un heterociclo o un aliciclo, activos sobre el sistema nervioso central.
ATE37533T1 (de) Derivate der 4-phenyl-4-oxo-buten-2-saeure, verfahren zu ihrer herstellung, medikamente und mischungen mit diesen derivaten.
JPS6468356A (en) Novel 1,2,5,6-tetrahydropyridine-3-carboxaldehydro oxime derivatives, use as drug and composition
MX9205365A (es) Imidazolilmetil-piridinas y composicion farmaceutica que las contiene.
DE69527789D1 (de) Mittel zur behandlung von kachexie die im zusammenhang mit tumoren steht
DE3064276D1 (en) 2-(2-chloro-4-cyclopropyl-phenyl-imino)-imidazolidine, acid addition salts thereof, medicaments based on such compounds and preparation process thereof
KR900014372A (ko) 티에닐피페라진 이의 제조방법 및 이를 함유하는 약제
KR940002268A (ko) 21-클로로-프레그난 유도체
GB916139A (en) Quinazolone derivatives
SE7707367L (sv) Sett att framstella nya glycinamider
DK0457680T3 (da) Derivater af oximen af 1,2,5,6-tetrahydropyridin-3-carboxaldehyd, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
MX9200022A (es) Nuevos derivados de acidos quinolincarboxilicos y procedimiento para su preparacion

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203